{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:55:40Z","timestamp":1761710140468,"version":"3.41.2"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cytomegalovirus (CMV) infection is a frequent complication among hematopoietic stem cell transplant (HSCT) recipients. Data regarding CMV reactivation in children in underdeveloped countries is scarce. This is especially notable considering the increasing utilization of haploidentical\u2010related HSCT with the post\u2010transplant cyclophosphamide platform. This study aimed to describe the incidence, clinical characteristics, and evolution of children with CMV reactivation after HSCT and the possible impact of unmanipulated stem cells with PTCy for GvHD prophylaxis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective cohort study of children undergoing hematopoietic stem cell transplantation from January 2012 to June 2022. Baseline characteristics and the clinical course were described. Duration of treatment, initial viral load, and time to clearance of DNAemia by type of transplant were compared using the Kruskal\u2010Wallis test. Survival analysis was performed with the Kaplan\u2013Meier method and log\u2010rank test. All statistical analysis was performed using SPSS software, version 20.0.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred sixty\u2010six children were included. Among them, 87% of recipients and 88% of donors were CMV positive. The cumulative incidence of cytomegalovirus DNAemia was 28% at 100\u2009days post\u2010transplantation. There were no differences between different donor types. Overall survival at 1\u2009year was 60%, and non\u2010relapse mortality was observed in 28%. CMV reactivation did not appear to negatively impact 1\u2010year overall survival (OS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study found no differences in CMV reactivation rates, treatment duration, viral clearance times, co\u2010infections, or 1\u2010year overall survival across different HSCT donor types. Studies are needed to establish more precise criteria for monitoring recipients, particularly in regions where unmanipulated stem cells with PTCy for GvHD prophylaxis are increasing.<\/jats:p><\/jats:sec>","DOI":"10.1111\/petr.70033","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T03:06:37Z","timestamp":1737515197000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["<scp>CMV<\/scp> Reactivation Following Allogeneic Transplantation in Children From a High\u2010Seroprevalence Population: A Single\u2010Center Experience in Colombia"],"prefix":"10.1111","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8176-7267","authenticated-orcid":false,"given":"Andres","family":"Arias","sequence":"first","affiliation":[{"name":"Hospital Universitario Erasmo Meoz  C\u00facuta Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8918-0065","authenticated-orcid":false,"given":"Natalia","family":"Builes","sequence":"additional","affiliation":[{"name":"Hospital Pablo Tob\u00f3n Uribe  Medell\u00edn Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7650-6057","authenticated-orcid":false,"given":"Laura","family":"Ni\u00f1o\u2010Serna","sequence":"additional","affiliation":[{"name":"Universidad de Antioquia  Medell\u00edn Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0525-9276","authenticated-orcid":false,"given":"Alejandro","family":"Diaz","sequence":"additional","affiliation":[{"name":"Hospital Pablo Tob\u00f3n Uribe  Medell\u00edn Colombia"},{"name":"Hospital General de Medell\u00edn  Medell\u00edn Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7697-4915","authenticated-orcid":false,"given":"Beatriz H.","family":"Aristizabal","sequence":"additional","affiliation":[{"name":"UNIGEM, Unidad de Investigaci\u00f3n Gen\u00e9tica Molecular  Medell\u00edn Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1398-901X","authenticated-orcid":false,"given":"Monica","family":"Trujillo","sequence":"additional","affiliation":[{"name":"Hospital Pablo Tob\u00f3n Uribe  Medell\u00edn Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185\u2010010\u20100569\u2010x"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-01751-4_25-1"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.655"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102003\u201010\u20103616"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-018-0960-y"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.07.003"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.08.014"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409\u2010022\u201001630\u20109"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.07.004"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000167987"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw668"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13498"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14324"},{"issue":"1","key":"e_1_2_10_15_1","first-page":"78","article-title":"Risk Factors for the Development of Cytomegalovirus Disease After Allogeneic Stem Cell Transplantation","volume":"91","author":"Ljungman P.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02660-8"},{"key":"e_1_2_10_17_1","doi-asserted-by":"crossref","unstructured":"M.Gooptu R.Romee A.St Martin et\u00a0al. \u201cHLA\u2010Haploidentical vs Matched Unrelated Donor Transplants With Posttransplant Cyclophosphamide\u2010Based Prophylaxis \u201dhttp:\/\/ashpublications.org\/blood\/article\u2010pdf\/138\/3\/273\/1814757\/bloodbld2021011281.pdf.","DOI":"10.1182\/blood.2021011281"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.3541"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009362"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2010.11.011"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268808000551"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13206"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246191"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piad059"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/petr.70033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T12:48:30Z","timestamp":1737982110000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/petr.70033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1111\/petr.70033"],"URL":"https:\/\/doi.org\/10.1111\/petr.70033","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"type":"print","value":"1397-3142"},{"type":"electronic","value":"1399-3046"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"2024-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70033"}}